Cole W D Peters

Title: Cole W D Peters: Innovator in Gene Therapy

Introduction

Cole W D Peters is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of hearing loss and blindness. His innovative work has the potential to change the lives of many individuals affected by these conditions.

Latest Patents

Cole W D Peters holds a patent for "AAV vectors encoding mini-PCDH15 and uses thereof." This patent focuses on compositions, nucleic acids, vectors, and viruses that are useful for treating hearing loss and/or blindness, specifically Usher Syndrome type IF. The disclosure provides isolated nucleic acids, vectors, and rAAV.9.PHP.B that comprise a transgene encoding a mini-PCDH15. Additionally, it outlines methods for treating hearing loss using these innovations. The patent also includes a gRNA associated with a base editor to correct mutations in PCDH15, which can aid in treating hearing loss and vision loss.

Career Highlights

Throughout his career, Cole has worked with esteemed institutions such as Harvard College and The Ohio State University. His research has focused on developing advanced therapeutic strategies that leverage gene editing technologies to address genetic disorders.

Collaborations

Cole has collaborated with notable colleagues in his field, including David P Corey and Artur Indzhykulian. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in gene therapy.

Conclusion

Cole W D Peters is a key figure in the advancement of gene therapy, with a focus on treating hearing and vision impairments. His contributions through patents and collaborations highlight the importance of innovation in addressing genetic disorders.